Cargando…

Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial)

Pravastatin has demonstrated anti-tumor activity in preclinical and clinical studies. This multicentric randomized double-blind placebo-controlled phase II study (NCT01418729) investigated the efficacy and safety of sorafenib + pravastatin combination on the overall survival (OS) and time to progres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riaño, Ioana, Martín, Leticia, Varela, Maria, Serrano, Trinidad, Núñez, Oscar, Mínguez, Beatriz, Rodrigues, Pedro M., Perugorria, Maria J., Banales, Jesus M., Arenas, Juan I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409102/ https://www.ncbi.nlm.nih.gov/pubmed/32674461 http://dx.doi.org/10.3390/cancers12071900

Ejemplares similares

Effect of pravastatin on the survival of patients with advanced gastric cancer
por: Bujanda, Luis, et al.
Publicado: (2015)

Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
por: Agirre-Lizaso, Aloña, et al.
Publicado: (2023)

Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models
por: Hijona, Elizabeth, et al.
Publicado: (2012)

Neutrophil-to-lymphocyte ratio predicts survival in European patients with hepatocellular carcinoma administered sorafenib
por: Lué, Alberto, et al.
Publicado: (2017)

Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma
por: Soria, Anna, et al.
Publicado: (2022)

TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms
por: Esparza-Baquer, Aitor, et al.
Publicado: (2021)

Extracellular Vesicles in Hepatobiliary Malignancies
por: Lapitz, Ainhoa, et al.
Publicado: (2018)

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
por: Kawata, S, et al.
Publicado: (2001)

Pravastatin for prevention of HELLP syndrome: A case report
por: Otten, Lucia Anna, et al.
Publicado: (2017)

Pravastatin reduces plasma levels of extracellular vesicles in pregnancies at high risk of term preeclampsia
por: Santoyo, Jean Michell, et al.
Publicado: (2023)

Effect of Pravastatin on Echocardiographic Circulation Parameters in Dogs
por: ARITA, Shinji, et al.
Publicado: (2013)

Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018)

Pravastatin-Induced Eczematous Eruption Mimicking Psoriasis
por: Salna, Michael P., et al.
Publicado: (2017)

Effect of Pravastatin and Simvastatin on the Reduction of Cytochrome C
por: Csomó, Krisztián, et al.
Publicado: (2022)

Pravastatin Transdermal Patches: Effect of The Formulation and Two Different Lengths of Microneedles on In-vitro Percutaneous Absorption Studies
por: Castañeda, Pablo Serrano, et al.
Publicado: (2020)

Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice
por: Lorza-Gil, Estela, et al.
Publicado: (2019)

Pravastatin reduces radiation-induced damage in normal tissues
por: Doi, Hiroshi, et al.
Publicado: (2017)

Pravastatin in preeclampsia: A meta-analysis and systematic review
por: Mészáros, Balázs, et al.
Publicado: (2023)

Effects of pravastatin on the pharmacokinetic parameters of nimodipine after oral and intravenous administration in rats: Possible role of CYP3A4 inhibition by pravastatin
por: Lee, Chong-Ki, et al.
Publicado: (2012)

Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma
por: Ikeda, Atsuyuki, et al.
Publicado: (2021)

Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
por: Mousa, Ali Ben
Publicado: (2008)

Sorafenib for the treatment of unresectable hepatocellular carcinoma
por: Furuse, Junji
Publicado: (2008)

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: Sanoff, Hanna K., et al.
Publicado: (2016)

Characterization of Human Erythrocytes as Potential Carrier for Pravastatin: An In Vitro Study
por: Harisa, Gamal El-din I., et al.
Publicado: (2011)

Pravastatin Provides Antioxidant Activity and Protection Of Erythrocytes Loaded Primaquine
por: Alanazi, Fars
Publicado: (2010)

Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice
por: Park, Kyung-Yeon, et al.
Publicado: (2016)

Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products
por: Ruiz-Picazo, Alejandro, et al.
Publicado: (2019)

Formulation Development and Evaluation of Pravastatin-Loaded Nanogel for Hyperlipidemia Management
por: Saraogi, Gaurav Kant, et al.
Publicado: (2022)

Computation-Aided Engineering of Cytochrome P450 for the Production of Pravastatin
por: Ashworth, Mark A., et al.
Publicado: (2022)

Characterizing the Heterogeneity of Liver Cell Populations Under a NASH-Related Hepatotoxicant Using Single-Nuclei RNA Sequencing
por: Rodrigues, Pedro M., et al.
Publicado: (2020)

Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma
por: Marta, Guilherme Nader, et al.
Publicado: (2021)

Pravastatin But Not Simvastatin Improves Survival and Neurofunctional Outcome After Cardiac Arrest and Cardiopulmonary Resuscitation
por: Bergt, Stefan, et al.
Publicado: (2017)

Cerebrovascular Accidents Associated with Sorafenib in Hepatocellular Carcinoma
por: Saif, Muhammad W., et al.
Publicado: (2011)

Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
por: Almhanna, Khaldoun, et al.
Publicado: (2009)

Evolving role of Sorafenib in the management of hepatocellular carcinoma
por: Ziogas, Ioannis A, et al.
Publicado: (2017)

Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
por: Ko, Yi-Ling, et al.
Publicado: (2020)

Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
por: Kissel, Maria, et al.
Publicado: (2017)

Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
por: Lee, Sangheun, et al.
Publicado: (2013)

Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis
por: Liu, Qinqin, et al.
Publicado: (2021)

Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats
por: Nozaki, Yoshihiro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m56ceii5ljvp0vishnnf9cqbpb